TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/26/2026
Back to search
Official data from USPTO
MYRIAD GENETICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
05/29/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
04/21/2021
Registration date
03/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2023
Last transaction
05/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2022-02-00
First use in commerce
2022-02-00
Drawing code
3
Owner type
03
Owner location
Salt Lake City, UT, US
Examiner
DE JONGE, KATHLEEN
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "MYRIAD" with the "M" appearing as a capital letter formed by four (4) lines that do not touch, and the remainder of the word appearing in lowercase letters, and the word "GENETICS" directly below "MYRIAD" appearing in lowercase letters.
Holders and representatives
Holders
Myriad Genetics, Inc.
Representatives
Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical test kits comprising chemical reagents and chemical preparations for medical use in connection with the detection of gene mutationsgene expression profilesother molecular abnormalitiesindicatorsmarkers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; medical diagnostic reagentsassayschemical preparationsdiagnostic test kits consisting primarily of reagents for medical diagnostic purposestesting of fluids; chemical reagents for medical use in connection with the detection of gene mutationsgene expression profilesother molecular abnormalitiesindicatorsmarkers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic test kits comprised of chemical reagents and chemical preparations for medical use in connection with the detection of gene mutationsgene expression profilesother molecular abnormalitiesindicatorsmarkers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic kits consisting primarily of reagents for body fluid analysis and nucleic acid analysis and for detecting genetic conditionsdisordersdiseases for medical use
Class 10
Medical test kits comprising specimen collection tubes and containers for collecting patient specimensprinted test formsprinted mailing materialsprinted user information inserts used in connection with the detection of gene mutationsgene expression profilesother molecular abnormalitiesindicatorsmarkers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; sample preparation device for medical diagnostic uses; medical apparatus and instruments for diagnostic useapparatus for medical diagnostic testing in the fields of tissue-based diagnostic testingcytology and cell-based testing; bloodurinesaliva medical specimen collection kits consisting of test tubes and self-mailerused for health and genetic analysis and diagnostics
Publications
History of USPTO decisions and trademark events.
55 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/26/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/26/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/26/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/26/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/09/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/09/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/21/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/14/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/13/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/04/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/04/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/03/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
02/03/2023
EX2G
SOU EXTENSION 2 GRANTED
02/03/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/25/2023
IUAF
USE AMENDMENT FILED
12/15/2022
DRRR
DIVISIONAL REQUEST RECEIVED
12/15/2022
EXT2
SOU EXTENSION 2 FILED
12/15/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
12/15/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2022
EISU
TEAS STATEMENT OF USE RECEIVED
12/15/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/27/2022
EX1G
SOU EXTENSION 1 GRANTED
07/25/2022
EXT1
SOU EXTENSION 1 FILED
07/25/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/25/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/17/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/17/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/17/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/17/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/27/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/27/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/27/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/27/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/25/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/30/2021
PUBO
PUBLISHED FOR OPPOSITION
11/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/25/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/25/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/25/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/25/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/25/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/08/2021
GNRT
NON-FINAL ACTION E-MAILED
09/08/2021
CNRT
NON-FINAL ACTION WRITTEN
09/08/2021
DOCK
ASSIGNED TO EXAMINER
09/06/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2021
NWAP
NEW APPLICATION ENTERED
04/24/2021
Continuous trademark protection
Get notified about every new filing that threatens MYRIAD GENETICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.